C, grew at a slower rate than in the prior fiscal year first
quarter, resulting in a $10.8 million reduction in cash used to fund
inventory increases. For the fiscal 2008 first quarter, substantially all
of the Specialty Chemicals segment sales occurred in the first two months
of the quarter and substantially all of the cash was collected prior to
December 31, 2007. As a result, cash provided from accounts receivable
balances during the fiscal 2008 first quarter improved by $9.3 million
compared to the prior year quarter. We consider these working capital
changes to be routine and within the normal production cycle of our
products. The production of certain fine chemical products requires a
length of time that exceeds one quarter. Therefore, in any given quarter,
work-in-progress inventory can increase or decrease significantly. We
expect that our working capital may vary normally by as much as $10.0
million from quarter to quarter.
Cash used for interest decreased primarily due to the timing of the
interest payments. Our current debt instruments require semi-annual
interest payments in February and August compared to the debt instruments
in place during the prior fiscal year first quarter which required interest
payments at the end of each quarter.
Cash used for environmental remediation decreased because during the
fiscal 2007 first quarter we were in the construction phase of our
Henderson, NV remediation project compared to the lower cash requirements
of the operating and maintenance phase which began in the fiscal 2007
second quarter.
Capital Expenditures -- Cash used for capital expenditures was
consistent between the fiscal 2008 and fiscal 2007 first quarters. We
expect that the amount of quarterly capital expenditures will increase as
we proceed through fiscal 2008 primarily in support of additional equipment
at AFC and capital expenses associated with the relocation of our corporate
offices.
OUTLOOK
Our fiscal 2008 first q
'/>"/>
SOURCE American Pacific Corporation Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Related medicine news :1.
Data From Antheras Plasma Trial to be Presented as Late Breaker at American College Of Cardiology Scientific Sessions2.
American Red Cross Responds to Tornadoes in the Southeast3.
Dr. Neil Sadick Presents on Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology4.
Massive American Red Cross Tornado Relief Effort Spans Five States5.
Sodium Content Foods and Beverages Gain Revenues as Americans are Embracing Low- and No-Sodium Campaigns6.
Vitals.com Goes Red for American Heart Month7.
American Heart Month: Cracking Open Heart Health Myths8.
Consumer Reports Poll: Americans Demand Health Reform But Are Unsure About How to Achieve it9.
Statement by Daniel W. Jones, M.D., American Heart Association President on President Bushs FY 2009 Budget Proposal10.
Senetek PLC Announces Debut of Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology11.
Shareholder Class Action Filed Against American Dental Partners, Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP